202 related articles for article (PubMed ID: 10528180)
1. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
Honey K; Cobbold SP; Waldmann H
J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
[TBL] [Abstract][Full Text] [Related]
2. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
3. Linked suppression of skin graft rejection can operate through indirect recognition.
Wise MP; Bemelman F; Cobbold SP; Waldmann H
J Immunol; 1998 Dec; 161(11):5813-6. PubMed ID: 9834057
[TBL] [Abstract][Full Text] [Related]
4. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
Jones ND; Van Maurik A; Hara M; Spriewald BM; Witzke O; Morris PJ; Wood KJ
J Immunol; 2000 Jul; 165(2):1111-8. PubMed ID: 10878390
[TBL] [Abstract][Full Text] [Related]
5. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
Ito H; Kurtz J; Shaffer J; Sykes M
J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
[TBL] [Abstract][Full Text] [Related]
6. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
7. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
8. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
9. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells.
Kurtz J; Ito H; Wekerle T; Shaffer J; Sykes M
Am J Transplant; 2001 Nov; 1(4):339-49. PubMed ID: 12099378
[TBL] [Abstract][Full Text] [Related]
11. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
12. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
13. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
14. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
van Maurik Av; Herber M; Wood KJ; Jones ND
J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
[TBL] [Abstract][Full Text] [Related]
16. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
Bumgardner GL; Orosz CG
Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
[TBL] [Abstract][Full Text] [Related]
17. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
Nakayama Y; Brinkman CC; Bromberg JS
Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
[TBL] [Abstract][Full Text] [Related]
18. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
19. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
